雑誌文献を検索します。書籍を検索する際には「書籍検索」を選択してください。

検索

書誌情報 詳細検索 by 医中誌

Japanese

Personalized Medicine for Epilepsy Based on the Pharmacogenomic Testing Shuichi Yoshida 1,2 , Takayuki Sugawara 2,3 , Takuhiro Nishio 1 , Sunao Kaneko 2 1Department of Integrated Human Sciences,Hamamatsu University School of Medicine 2Department of Neuropsychiatory,Hirosaki University Graduate School of Medicine 3Institute of Bio-System Informatics,Tohoku Chemical Co.,Ltd. Keyword: pharmacogenomic testing , antiepileptic drug , cytochrome P450 , drug transporter , extensive/poor metabolizer pp.295-299
Published Date 2011/4/1
DOI https://doi.org/10.11477/mf.1416100872
  • Abstract
  • Look Inside
  • Reference

Abstract

 Currently a trial-and-error approach is employed to determine the most effective antiepileptic drug (AED) and dosage for a patient, and almost 30% of all patients are resistant to AED therapy. Introduction of personalized medicine for epilepsy based on pharmacogenomic testing is a new avenue for optimizing AED therapy. However, several crucial issues remain to be resolved before this initiative can be fully pursued.

 This article provides a critical review of the status and perspectives in the development of personalized medicine for epilepsy based on pharmacogenetic variations that may affect efficacy,tolerability,and safety of AEDs,such as variations in the genes encoding drug-metabolizing enzymes (e.g.,cytochrome P450),or drug transporters (e.g.,MDR1,MRP2).


Copyright © 2011, Igaku-Shoin Ltd. All rights reserved.

基本情報

電子版ISSN 1344-8129 印刷版ISSN 1881-6096 医学書院

関連文献

もっと見る

文献を共有